Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ipilimumab in patients with melanoma and autoimmune disease.
Regulatory B Cells and Mechanisms.
Estimating a minimal clinically important difference for the EuroQol 5-dimension health status index in persons with multiple sclerosis.
A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.
Frequent Infection of Neurons by SV40 Virus in SIV-Infected Macaque Monkeys with Progressive Multifocal Leukoencephalopathy and Meningoencephalitis.
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care.
The effect of wheelchair use on the quality of life of persons with multiple sclerosis.
Standing Data Disproves Biomechanical Mechanism for Balance-Based Torso-Weighting.
Fatigue in multiple sclerosis is not due to sleep apnoea.
A case of relapsing-remitting tumour-like inflammation of the central nervous system.
Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.
Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients.
A role for HLA-DRB1*1101 and DRB1*0801 in cognitive ability and its decline with age.
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.
Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?
Expression profiling of the ubiquitin conjugating enzyme UbcM2 in murine brain reveals modest age-dependent decreases in specific neurons.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.
High-throughput sequencing of immune repertoires in multiple sclerosis.
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
Pages
« first
‹ previous
…
594
595
596
597
598
599
600
601
602
…
next ›
last »